Article Details

Pfizer Gets CDSCO Panel Nod To study Osivelotor in sickle cell disease

Retrieved on: 2024-03-19 19:27:24

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Gets CDSCO Panel Nod To study Osivelotor in sickle cell disease. View article details on hiswai:

Excerpt

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up